Evidence map›Paper›PMID 34659685›Full record

ArticleJournal of healthcare engineering2021

Peroneal Electric Transcutaneous NeuroModulation (eTNM

Jan Krhut, Lukas Peter, Michal Rejchrt, Martin Slovak, Barbora Skugarevska, Peter Zvara

Open access · hybridAbstract read
In one paragraph

Article in Journal of healthcare engineering, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Review
  3. Observational
  4. Review
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

Jan KrhutDepartment of Urology, University Hospital, Ostrava, Czech Republic.ORCID 0000-0003-4205-5926
Lukas PeterSTIMVIA™, Ostrava, Czech Republic.
Michal RejchrtDepartment of Urology, 2nd Faculty of Medicine of Charles University and Motol University Hospital, Prague, Czech Republic.
Martin SlovakSTIMVIA™, Ostrava, Czech Republic.
Barbora SkugarevskaDepartment of Urology, University Hospital, Ostrava, Czech Republic.
Peter ZvaraBiomedical Laboratory and Research Unit of Urology Department of Clinical Research, University of Southern Denmark, Odense, Denmark.ORCID 0000-0002-6972-6980
University of Ostrava · CZCharles University · CZUniversity of Hradec Králové · CZUniversity of Southern Denmark · DK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Overactive bladder syndrome (OAB) is a prevalent medical problem with a significant impact on the quality of life of the affected individuals. Pharmacotherapy is considered the main treatment method, although it is discontinued in a significant proportion of patients due to inefficacy or associated side effects. If pharmacotherapy fails, patients can undergo peripheral neuromodulation of the somatic nerves of the lower limb or sacral neuromodulation; however, neither of these represents an ideal therapeutic tool. The Peroneal electric Transcutaneous NeuroModulation (Peroneal eTNM

Indexed as

Electric Stimulation TherapyTelemedicineUrinary Bladder, OveractiveElectrodesHumansQuality of LifeUnited States

Identifiers

PMID34659685
PMCPMC8514907
OpenAlexW3202235224

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.